Related Experiment Video
Updated: May 30, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Inhibition of melanoma cell proliferation by targeting Wnt/β-catenin pathway through Sox4 RNA interference
Huahua Cai1, Anhong Ni1, Wen Li1
1Department of Dermatology and Venereology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Abstract:
The effect of siRNA-mediated Sox4 gene silencing on Wnt/β-catenin signaling pathway of human malignant melanoma cell line A375 was investigated. Two types of dsRNA targeting Sox4 were constructed and transfected into A375 cells, and untreated cells and cells transfected with scramble RNA were used as blank control and negative control respectively. The expression levels of mRNA and protein of Sox4, Wnt3a, β-catenin and Wnt/β-catenin signaling target gene Survivin were detected after real-time PCR and Western blot respectively. MTT assay was used to measure cell proliferation after Sox4 knockdown. β-catenin/TCF transcription reporter assay was used for assessing Wnt/β-catenin signaling pathway activity. Our results showed that the two types of Sox4 siRNA were transfected into A375 cells successfully. As compared with untreated cells, Sox4 siRNAs had no significant influence on Wnt3a expression, and Sox4 siRNAs led to the decrease of β-catenin at protein level. Wnt/β-catenin signaling pathway activity was inhibited significantly. As a target of Wnt/β-catenin signaling, Survivin was decreased at both mRNA and protein levels, and cell proliferation was attenuated. Our study suggests that Sox4 may play an important role in Wnt/β-catenin signaling pathway in human malignant melanoma cells by regulating β-catenin protein level, indicating that Sox4 is involved in the progression of malignant melanoma through Wnt/β-catenin signaling pathway.
Insights
Sox4 gene silencing in melanoma cells reduced beta-catenin protein, inhibiting the Wnt/beta-catenin pathway and decreasing cell proliferation. This suggests Sox4 promotes malignant melanoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Wnt/β-catenin signaling pathway is crucial in various cancers, including malignant melanoma.
- Sox4, a transcription factor, has been implicated in cancer progression, but its role in melanoma signaling is not fully understood.
Purpose of the Study:
- To investigate the effect of Sox4 gene silencing on the Wnt/β-catenin signaling pathway in the human malignant melanoma cell line A375.
- To determine if Sox4 influences melanoma cell proliferation via this pathway.
Main Methods:
- Sox4 gene silencing was achieved using small interfering RNA (siRNA) in A375 cells.
- Real-time PCR and Western blot were used to measure gene and protein expression of Sox4, Wnt3a, β-catenin, and Survivin.
- MTT assays and β-catenin/TCF transcription reporter assays assessed cell proliferation and pathway activity, respectively.
Main Results:
- Sox4 siRNA successfully reduced Sox4 expression without affecting Wnt3a levels.
- Sox4 knockdown led to decreased β-catenin protein levels and significantly inhibited Wnt/β-catenin pathway activity.
- The expression of Survivin, a target gene, decreased, and melanoma cell proliferation was attenuated.
Conclusions:
- Sox4 plays a significant role in regulating the Wnt/β-catenin signaling pathway in malignant melanoma cells.
- Sox4 influences melanoma progression by modulating β-catenin protein levels and downstream signaling, suggesting it as a potential therapeutic target.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
Non-Canonical Wnt Signaling Pathways
Pleiotropy